Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
CUE
$25.25
-2.40%
CUE
· Cue Biopharma, Inc.
$25.25
-0.62 (-2.40%)
At close · Oct 1
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 14, 2026
The latest filing no longer states the doubt (first flagged May 14, 2026).
View the 10-Q filed Aug 14, 2026Market Cap
$194.11M
Shares
7.26M
Volume · Oct 1
183.43K
Avg daily vol (3M)
262.97K
All webcasts
Earnings call · FY2026 Q2
Cue Biopharma, Inc. (CUE) Q2 2026 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue
$7.88M
+166.7% YoY
Diluted EPS
-$24.14
Net income
-$153.07M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 14, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 14, 2026 · complete as-filed document